Elapid neurotoxin (NTX)

Neurotoxic snake venom toxins from the Elapidae family, including cobras, mambas, and sea snakes, are a diverse group of proteins that evolved to rapidly immobilize prey by disrupting the nervous system. The most prominent members are the three-finger toxins (3FTxs), characterized by a conserved structural motif of three beta-stranded loops extending from a central core. These toxins target critical components of the peripheral nervous system, most notably the nicotinic acetylcholine receptors at the neuromuscular junction, leading to muscle weakness and fatal respiratory paralysis. In a clinical context, these toxins are the primary drivers of morbidity and mortality in elapid snakebites. Therapeutic intervention relies heavily on the administration of antivenoms, which consist of purified antibodies that neutralize the toxins in circulation. Emerging research is also exploring small-molecule inhibitors, such as varespladib for phospholipase-based toxins, to provide more stable and accessible field treatments. Understanding the specific molecular interactions between these toxins and their human targets is essential for developing next-generation synthetic antivenoms and potential neuro-modulatory drugs.

Other names

Snake venom neurotoxinThree-finger toxin3FTxAlpha-neurotoxinBeta-neurotoxinPost-synaptic neurotoxinPre-synaptic neurotoxinDendrotoxin

Elapid neurotoxins primarily function through two mechanisms: post-synaptic blockade and pre-synaptic inhibition. Post-synaptic alpha-neurotoxins (three-finger toxins) bind with high affinity and specificity to nicotinic acetylcholine receptors (nAChR) at the neuromuscular junction, competitively inhibiting acetylcholine binding and preventing muscle contraction. Pre-synaptic neurotoxins, often possessing phospholipase A2 activity, damage nerve terminals and inhibit the release of neurotransmitters, leading to a more persistent and difficult-to-reverse paralysis.